Skip to main content
NC Medicaid logo NC Medicaid

Topical Navigation

  • Home
  • Beneficiaries
  • Meetings & Notices
  • Find a Doctor
  • Providers
  • Counties
  • Reports
  • ABOUT US
  • NC.GOV
  • NCDHHS
  • SERVICES
NC Medicaid »   Home »   blog

SPECIAL BULLETIN COVID-19 #107: Continuation of COVID-19 Enhanced Rates

July 8, 2020

NC Medicaid is committed to ensuring beneficiaries continue to receive Medicaid and NC Health Choice services with no interruptions or delays due to the novel coronavirus (COVID-19) outbreak. 

NC Medicaid has temporarily enhanced many reimbursement rates, including medical home per member per month payments, to support health care providers in delivering Medicaid services. NC Medicaid also committed to evaluating the need for and possibility of extending these temporary enhanced Medicaid rates past June 30, 2020. NC Medicaid has determined that it is both necessary and feasible to continue all of these enhanced rates into the new State Fiscal Year.  

While NC Medicaid will continue to evaluate evolving circumstances, we anticipate keeping the current temporary enhanced rates in place through September 2020. We will provide updates through subsequent bulletins as we move into the fall and reassess both needs and available funding.

Base rates for programs that require periodic updates per the NC Medicaid State Plan will continue to be updated as scheduled. COVID-19 enhanced rates for these programs will be recalculated using the applicable updated base rates.

Criteria for COVID-19 enhanced rates established in previous Special Bulletins will remain the same. For a schedule of rates, please refer to the Medicaid fee schedule webpage.

NC Medicaid will provide updates and additional details in upcoming COVID-19 Special Medicaid Bulletins.

Contact

NCTracks Contact Center: 800-688-6696

This blog is related to:

  • Bulletins
  • COVID-19

Related Articles

  • Billing Requirement Modifications Due to COVID-19 to Expire
  • Verifying Provider Information (NPI+Location Code) in NCTracks
  • Lutetium Lu 177 Vipivotide Tetraxetan Injection, for Intravenous Use (Pluvicto™) HCPCS Code A9699: Billing Guidelines
  • Kit for the Preparation of Gallium Ga 68 Dotatate Injection, for Intravenous Use (Netspot®) HCPCS Code A9587: Billing Guidelines
  • Kit for the Preparation of Gallium Ga 68 Gozetotide Injection, for Intravenous Use (Locametz®) HCPCS Code A9597: Billing Guidelines
  • Gadoterate Meglumine Injection, for Intravenous Use (Clariscan™) HCPCS Code A9575: Billing Guidelines
  • Free Dental Continuing Education Credits
  • Ephedrine Hydrochloride Injection, for Intravenous use (Rezipres®) HCPCS code J3490: Billing Guidelines
  • Filgrastim-ayow Injection, for Subcutaneous or Intravenous Use (Releuko®) HCPCS Code J3590: Billing Guidelines
  • Nivolumab and Relatlimab-rmbw Injection, for Intravenous Use (Opdualag™) HCPCS Code J9999: Billing Guidelines
  • Difelikefalin Injection, for Intravenous use (Korsuva™) HCPCS code J0879 - Injection, difelikefalin, 0.1 microgram, (for ESRD on Dialysis): Billing Guidelines
  • Sutimlimab-jome Injection, for Intravenous Use (Enjaymo™) HCPCS Code J3590: Billing Guidelines
  • One Year Anniversary of New Service to Ensure Communication Access in Health Care Settings
  • SPECIAL BULLETIN COVID-19 #247: Over-the-Counter COVID-19 Tests for Home Use Pharmacy Coverage
  • Healthy Opportunities Housing and Transportation Services Available

Share this page:

  • Facebook
  • Twitter
  • Email
Back to top

Contact Information

NC Medicaid
Division of Health Benefits

2501 Mail Service Center
Raleigh, NC 27699-2501
 
NC Medicaid Contact Center
Phone: 888-245-0179
Monday-Friday 8 a.m. to 5 p.m.
Closed on State holidays. 
 
Visit RelayNC for information about TTY services. 
 
More
 

Recent Tweets

Tweets by @ncdhhs

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • EMPLOYEE DIRECTORY
  • TRANSLATION DISCLAIMER
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Open Budget
NC Medicaid
https://medicaid.ncdhhs.gov/blog/2020/07/08/special-bulletin-covid-19-107-continuation-covid-19-enhanced-rates